ArticleEuropean journal of pediatrics2026
Extracriteria manifestations in Kawasaki disease: coronary threat or diagnostic pitfall?
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kawasaki disease (KD) may present with manifestations beyond classical diagnostic criteria, but data on extracriteria manifestations as a multisystem phenotype remain limited. We aimed to assess the frequency and clinical significance of extracriteria manifestations in children with KD. In this retrospective single-center study, we reviewed 254 children with KD between January 2005 and December 2025. Extracriteria manifestations were defined as clinically documented organ-system involvement beyond the five principal diagnostic criteria of KD after exclusion of alternative diagnoses. Patients were compared according to extracriteria manifestations with respect to demographic, clinical, laboratory, echocardiographic, treatment, and coronary outcome variables. Extracriteria manifestations were identified in 77 patients (30.3%). Gastrointestinal involvement was most common (13.4%), followed by cardiovascular (non-coronary) and neurological involvement. Patients with extracriteria manifestations were more often female (46.8% vs. 32.8%), had higher C-reactive protein levels, more frequent hypoalbuminemia, lower serum sodium levels, and longer hospitalization (all p < 0.05). Although the median admission-to-diagnosis interval was similar between groups, its distribution differed significantly, suggesting that a subset of patients with extracriteria manifestations experienced longer diagnostic delays. Coronary involvement, IVIG resistance, and follow-up coronary outcomes were similar between groups. In multivariable analysis, female sex (OR 1.81, 95% CI 1.01-3.24) and higher C-reactive protein levels (OR 1.04, 95% CI 1.00-1.09) were independently associated with extracriteria manifestations.
conclusionsExtracriteria manifestations are common in KD and are associated with greater inflammatory burden and longer hospitalization. Female sex and higher C-reactive protein levels were independently associated with extracriteria manifestations, whereas coronary involvement, IVIG resistance, and follow-up coronary outcomes were similar between groups. Early recognition of these presentations may facilitate timely diagnosis and management. WHAT IS KNOWN: • Kawasaki disease is a systemic vasculitis involving multiple organ systems beyond classical criteria, but reported frequencies vary widely due to inconsistent definitions. • Extracardiac manifestations often overlap with incomplete presentations and can lead to significant diagnostic challenges and delays. WHAT IS NEW: • Using a strict predefined definition, extracriteria manifestations were identified in 30.3% of patients; female sex and higher C-reactive protein levels were independently associated with extracriteria manifestations. • Extracriteria manifestations were associated with a greater inflammatory burden and longer hospitalization but not with coronary involvement, IVIG resistance, or adverse follow-up coronary outcomes.
Indexed as
Identifiers
42603200What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.